COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Since vaccination against coronavirus disease 2019 (COVID-19) became available, risks related to vaccinating patients with multiple sclerosis (MS) need to be carefully assessed. Characterize safety and occurrence of immediate relapses following COVID-19 vaccination in a large cohort of MS patients....

Celý popis

Podrobná bibliografie

Vydáno v:	Multiple sclerosis Ročník 27; číslo 6; s. 864
Hlavní autoři:	Achiron, Anat, Dolev, Mark, Menascu, Shay, Zohar, Daniela-Noa, Dreyer-Alster, Sapir, Miron, Shmuel, Shirbint, Emanuel, Magalashvili, David, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Polliack, Michael, Falb, Rina, Gurevich, Michael
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.05.2021
Témata:	COVID-19 Multiple sclerosis adverse events acute relapse immune response vaccination
ISSN:	1477-0970, 1477-0970
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!